Hepatitis por el virus C
作者： J Cabezas , S Llerena , S Menéndez , C Alonso Martín , J Crespo García
DOI: 10.1016/J.MED.2016.04.002
关键词: Humanities 、 Medicine
摘要: Resumen Epidemiologia La hepatitis C es una infeccion virica que afecta a unos 180 millones de personas en el mundo. Se trata la primera causa trasplante hepatico nuestro pais. Historia natural evolucion enfermedad aparicion cirrosis y aumento del riesgo desarrollo cancer hepatocelular. Manifestaciones clinicas Es silente, cuyo diagnostico mediante signos clinicos supone detectarla fases avanzadas, por ello gran importancia programas cribado. Diagnostico El inicial se realiza anticuerpos anti-VHC confirma demostrando replicacion virica. Indicacion tratamiento establece tras evaluacion grado fibrosis. Las nuevas tecnicas no invasiva fibrosis ecografia ultima generacion permiten estadificacion precisa rapida enfermedad. Antiviricos accion directa incorporacion los agentes antiviricos al arsenal terapeutico frente VHC ha supuesto un avance permite obtener elevadas tasas curacion, evitando empleo interferon ribavirina.
medicineonline.es
unirioja.es参考文章(43)
EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis. Journal of Hepatology. ,vol. 63, pp. 237- 264 ,(2015) , 10.1016/J.JHEP.2015.04.006
Clodoveo Ferri, HCV syndrome: A constellation of organ- and non-organ specific autoimmune disorders, B-cell non-Hodgkin’s lymphoma, and cancer World Journal of Hepatology. ,vol. 7, pp. 327- 343 ,(2015) , 10.4254/WJH.V7.I3.327
Markus Cornberg, Homie A. Razavi, Alfredo Alberti, Enos Bernasconi, Maria Buti, Curtis Cooper, Olav Dalgard, John F. Dillion, Robert Flisiak, Xavier Forns, Sona Frankova, Adrian Goldis, Ioannis Goulis, Waldemar Halota, Bela Hunyady, Martin Lagging, Angela Largen, Michael Makara, Spilios Manolakopoulos, Patrick Marcellin, Rui T. Marinho, Stanislas Pol, Thierry Poynard, Massimo Puoti, Olga Sagalova, Scott Sibbel, Krzysztof Simon, Carolyn Wallace, Kendra Young, Cihan Yurdaydin, Eli Zuckerman, Francesco Negro, Stefan Zeuzem, A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel. Liver International. ,vol. 31, pp. 30- 60 ,(2011) , 10.1111/J.1478-3231.2011.02539.X
D. Lavanchy, Evolving epidemiology of hepatitis C virus Clinical Microbiology and Infection. ,vol. 17, pp. 107- 115 ,(2011) , 10.1111/J.1469-0691.2010.03432.X
Fred Poordad, Christophe Hezode, Roger Trinh, Kris V. Kowdley, Stefan Zeuzem, Kosh Agarwal, Mitchell L. Shiffman, Heiner Wedemeyer, Thomas Berg, Eric M. Yoshida, Xavier Forns, Sandra S. Lovell, Barbara Da Silva-Tillmann, Christine A. Collins, Andrew L. Campbell, Thomas Podsadecki, Barry Bernstein, ABT-450/r-Ombitasvir and Dasabuvir with Ribavirin for Hepatitis C with Cirrhosis The New England Journal of Medicine. ,vol. 370, pp. 1973- 1982 ,(2014) , 10.1056/NEJMOA1402869
Julien Vergniol, Jérôme Boursier, Clélia Coutzac, Sandrine Bertrais, Juliette Foucher, Camille Angel, Faiza Chermak, Isabelle Fouchard Hubert, Wassil Merrouche, Frédéric Oberti, Victor de Lédinghen, Paul Calès, Evolution of noninvasive tests of liver fibrosis is associated with prognosis in patients with chronic hepatitis C Hepatology. ,vol. 60, pp. 65- 76 ,(2014) , 10.1002/HEP.27069
Adriaan J. van der Meer, Bart J. Veldt, Jordan J. Feld, Heiner Wedemeyer, Jean-François Dufour, Frank Lammert, Andres Duarte-Rojo, E. Jenny Heathcote, Michael P. Manns, Lorenz Kuske, Stefan Zeuzem, W. Peter Hofmann, Robert J. de Knegt, Bettina E. Hansen, Harry L. A. Janssen, Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis. JAMA. ,vol. 308, pp. 2584- 2593 ,(2012) , 10.1001/JAMA.2012.144878
Mark S. Sulkowski, David F. Gardiner, Maribel Rodriguez-Torres, K. Rajender Reddy, Tarek Hassanein, Ira Jacobson, Eric Lawitz, Anna S. Lok, Federico Hinestrosa, Paul J. Thuluvath, Howard Schwartz, David R. Nelson, Gregory T. Everson, Timothy Eley, Megan Wind-Rotolo, Shu-Pang Huang, Min Gao, Dennis Hernandez, Fiona McPhee, Diane Sherman, Robert Hindes, William Symonds, Claudio Pasquinelli, Dennis M. Grasela, Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection The New England Journal of Medicine. ,vol. 370, pp. 211- 221 ,(2014) , 10.1056/NEJMOA1306218
Javier Crespo, Joaquín Cabezas, Begoña Sacristán, José L. Olcoz, Ramón Pérez, Juan De la Vega, Rosa García, Félix García-Pajares, Federico Sáez-Royuela, José M. González, Felipe Jiménez, Santiago Rodríguez, Antonio Cuadrado, María J. López-Arias, Isidro García, Ana Milla, Emilia García-Riesco, María Muñoz, Gloria Sánchez-Antolín, Francisco Jorquera, Barriers to HCV treatment in the era of triple therapy: a prospective multi-centred study in clinical practice Liver International. ,vol. 35, pp. 401- 408 ,(2015) , 10.1111/LIV.12536
Mark Thursz, Arnaud Fontanet, HCV transmission in industrialized countries and resource-constrained areas Nature Reviews Gastroenterology & Hepatology. ,vol. 11, pp. 28- 35 ,(2014) , 10.1038/NRGASTRO.2013.179